Veteran Petitions Against State Hemp Restrictions Over Opioid Concerns

A U.S. military veteran has launched a petition challenging state restrictions on hemp-derived products, telling local news outlet WKRN that he turned to the alternatives specifically to avoid returning to opioid pain medication. The petition is directed at state lawmakers and calls for a closer look at the current rules governing the sale and possession of such items.

Why the veteran is pushing back

The veteran, who has spoken publicly about chronic pain linked to his service, said prescription opioids were the only option offered to him for years. He described the side effects and the risk of dependency as reasons he sought non-opioid alternatives, which he found in regulated hemp products. He told WKRN that restricting those products would, in his view, force patients like him back onto stronger medications.

What the petition asks for

The petition urges state officials to review the existing framework and to consider changes that would preserve patient access while still addressing safety concerns. Organisers say the goal is to start a broader conversation in the state legislature rather than to demand an immediate rollback of any single rule.

Broader context

Across several states, veterans and chronic-pain patients have increasingly advocated for hemp-derived options as part of a wider effort to reduce reliance on opioids. Related reporting has highlighted how something as small as a lost tag can underscore a veteran's connection to service — see one Louisiana couple's effort to return lost veteran dog tags found at a local shop — while other coverage has examined combined sleep disorders linked to increased diabetes risk in veterans, another sign of the long-term health issues veterans navigate. Meanwhile, a separate dispute over a proposed design for the Global War on Terrorism Memorial shows how veterans' causes continue to surface in public debates.

• Petition targets state hemp-product rules.
• Veteran cites a desire to avoid opioid painkillers.
• Organisers want a legislative review, not an immediate repeal.